Truist raised the firm’s price target on Phreesia (PHR) to $36 from $35 and keeps a Buy rating on the shares following a post-quarter call with management to discuss its AccessOne, Q2 results, 2026 expectations, among other topics. The firm notes the company posted solid Q2 results, with in-line revenues and adjusted EBITDA ahead of consensus and raised its FY26 EBITDA guidance.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHR:
- Phreesia’s Strong Financial Performance and Strategic Growth Initiatives Drive Buy Rating
- Phreesia price target raised to $33 from $30 at Raymond James
- Tesla’s big pay proposal for Musk, Wall Street sours on Lululemon: Morning Buzz
- Morning Movers: Broadcom up on earnings, unnamed new AI customer
- Phreesia price target raised to $35 from $29 at Needham